Ann Collier is an Infectious Disease physician affiliated with University of Washington. OpenAlex indexes 9 publications with 366 citations (h-index 8); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Harborview Medical Center
325 9th Ave
Seattle, WA 98104
Telephone
206-731-3000Registry record last updated 23 Jan 2012.
Clinical trials
- mHealth App for Changing Alcohol Use in Alaska Native American Indian People
Sponsor: Southcentral Foundation
- Study of Options for Second-Line Effective Combination Therapy (SELECT)
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
Sponsor: University of Washington
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
44.5%Opioid Agonist15.5%Oxycodone Hcl65%Morphine Sulfate Er35%Part D<11 patientsGabapentinoids12.2%Gabapentin100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
28.4%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor16.4%Isentress42%Tivicay38%Juluca20%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor11.9%Descovy73%Truvada28%Part D<11 patientsCardiovascular
9%Statin5.7%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker3.3%Amlodipine Besylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 1995–2022 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cognitive Risk Factors and Neuropsychological Performance in HIV Infection
International Journal of Neuroscience
1993
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”